BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 29303660)

  • 1. Acute megakaryoblastic leukemia (excluding Down syndrome) remains an acute myeloid subgroup with inferior outcome in the French ELAM02 trial.
    Teyssier AC; Lapillonne H; Pasquet M; Ballerini P; Baruchel A; Ducassou S; Fenneteau O; Petit A; Cuccuini W; Ragu C; Preudhomme C; Mercher T; Sirvent N; Leverger G
    Pediatr Hematol Oncol; 2017 Nov; 34(8):425-427. PubMed ID: 29303660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved outcome of pediatric patients with acute megakaryoblastic leukemia in the AML-BFM 04 trial.
    Schweitzer J; Zimmermann M; Rasche M; von Neuhoff C; Creutzig U; Dworzak M; Reinhardt D; Klusmann JH
    Ann Hematol; 2015 Aug; 94(8):1327-36. PubMed ID: 25913479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome and Prognostic Features in Pediatric Acute Megakaryoblastic Leukemia Without Down Syndrome: A Retrospective Study in China.
    Wang Y; Lu A; Jia Y; Zuo Y; Zhang L
    Clin Lymphoma Myeloma Leuk; 2021 Apr; 21(4):e301-e308. PubMed ID: 33257285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biology and outcome of childhood acute megakaryoblastic leukemia: a single institution's experience.
    Athale UH; Razzouk BI; Raimondi SC; Tong X; Behm FG; Head DR; Srivastava DK; Rubnitz JE; Bowman L; Pui CH; Ribeiro RC
    Blood; 2001 Jun; 97(12):3727-32. PubMed ID: 11389009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Characteristics and Prognosis of 27 Patients with Childhood Acute Megakaryoblastic Leukemia.
    Qi H; Mao Y; Cao Q; Sun X; Kuai W; Song J; Ma L; Hong Z; Hu J; Zhou G
    Med Sci Monit; 2020 Jun; 26():e922662. PubMed ID: 32532951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of specific molecular profiles in pediatric acute megakaryoblastic leukemia in non-Down syndrome.
    Hara Y; Shiba N; Ohki K; Tabuchi K; Yamato G; Park MJ; Tomizawa D; Kinoshita A; Shimada A; Arakawa H; Saito AM; Kiyokawa N; Tawa A; Horibe K; Taga T; Adachi S; Taki T; Hayashi Y
    Genes Chromosomes Cancer; 2017 May; 56(5):394-404. PubMed ID: 28063190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute Myeloid Leukemia With Central Nervous System Involvement in Children: Experience From the French Protocol Analysis ELAM02.
    Felix A; Leblanc T; Petit A; Nelkem B; Bertrand Y; Gandemer V; Sirvent A; Paillard C; Schmitt C; Rohrlich PS; Fenneteau O; Ragu C; Michel G; Auvrignon A; Baruchel A; Leverger G
    J Pediatr Hematol Oncol; 2018 Jan; 40(1):43-47. PubMed ID: 29189507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study of a pirarubicin, intermediate-dose cytarabine, and etoposide regimen in children with Down syndrome and acute myeloid leukemia: the Japanese Childhood AML Cooperative Study Group.
    Kudo K; Kojima S; Tabuchi K; Yabe H; Tawa A; Imaizumi M; Hanada R; Hamamoto K; Kobayashi R; Morimoto A; Nakayama H; Tsuchida M; Horibe K; Kigasawa H; Tsukimoto I;
    J Clin Oncol; 2007 Dec; 25(34):5442-7. PubMed ID: 18048827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute megakaryoblastic leukemia associated with trisomy 21 demonstrates a distinct immunophenotype.
    Wang L; Peters JM; Fuda F; Li L; Karandikar NJ; Koduru P; Wang HY; Chen W
    Cytometry B Clin Cytom; 2015; 88(4):244-52. PubMed ID: 25361478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute megakaryoblastic leukemia in children and adolescents: a retrospective analysis of 24 cases.
    Ribeiro RC; Oliveira MS; Fairclough D; Hurwitz C; Mirro J; Behm FG; Head D; Silva ML; Raimondi SC; Crist WM
    Leuk Lymphoma; 1993 Jul; 10(4-5):299-306. PubMed ID: 8220128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathologic, cytogenetic, and molecular features of acute myeloid leukemia with megakaryocytic differentiation: A report from the Children's Oncology Group.
    Chisholm KM; Smith J; Heerema-McKenney AE; Choi JK; Ries RE; Hirsch BA; Raimondi SC; Wang YC; Dang A; Alonzo TA; Sung L; Aplenc R; Gamis AS; Meshinchi S; Kahwash SB
    Pediatr Blood Cancer; 2023 May; 70(5):e30251. PubMed ID: 36789545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneous cytogenetic subgroups and outcomes in childhood acute megakaryoblastic leukemia: a retrospective international study.
    Inaba H; Zhou Y; Abla O; Adachi S; Auvrignon A; Beverloo HB; de Bont E; Chang TT; Creutzig U; Dworzak M; Elitzur S; Fynn A; Forestier E; Hasle H; Liang DC; Lee V; Locatelli F; Masetti R; De Moerloose B; Reinhardt D; Rodriguez L; Van Roy N; Shen S; Taga T; Tomizawa D; Yeoh AE; Zimmermann M; Raimondi SC
    Blood; 2015 Sep; 126(13):1575-84. PubMed ID: 26215111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological characteristics of extramedullary acute megakaryoblastic leukemia (AMKL): report of a case with initial mastoid presentation and review of literature to compare extramedullary AMKL and non-AMKL cases.
    Liang C; Chan KH; Yoon PJ; Lovell MA
    Pediatr Dev Pathol; 2012; 15(5):385-92. PubMed ID: 22667334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of childhood myelodysplastic syndrome, AML FAB M6 or M7, CCG 2891: report from the Children's Oncology Group.
    Barnard DR; Alonzo TA; Gerbing RB; Lange B; Woods WG;
    Pediatr Blood Cancer; 2007 Jul; 49(1):17-22. PubMed ID: 16856158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mosaic Down syndrome-associated acute myeloid leukemia does not require high-dose cytarabine treatment for induction and consolidation therapy.
    Kudo K; Hama A; Kojima S; Ishii R; Morimoto A; Bessho F; Sunami S; Kobayashi N; Kinoshita A; Okimoto Y; Tawa A; Tsukimoto I
    Int J Hematol; 2010 May; 91(4):630-5. PubMed ID: 20237876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biology, clinical, and hematologic features of acute megakaryoblastic leukemia in children.
    Paredes-Aguilera R; Romero-Guzman L; Lopez-Santiago N; Trejo RA
    Am J Hematol; 2003 Jun; 73(2):71-80. PubMed ID: 12749007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrastructural and ultracytochemical differences between megakaryoblastic leukemia in children and adults. Analysis of 49 patients.
    Eguchi M; Ozawa T; Sakakibara H; Sugita K; Iwama Y; Furukawa T
    Cancer; 1992 Jul; 70(2):451-8. PubMed ID: 1319816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical features and prognosis of pediatric acute megakaryocytic leukemia].
    Luo TM; Yu J; An XZ
    Zhongguo Dang Dai Er Ke Za Zhi; 2021 Jun; 23(6):613-620. PubMed ID: 34130784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Courses of Two Pediatric Patients with Acute Megakaryoblastic Leukemia Harboring the CBFA2T3-GLIS2 Fusion Gene.
    Ishibashi M; Yokosuka T; Yanagimachi MD; Iwasaki F; Tsujimoto SI; Sasaki K; Takeuchi M; Tanoshima R; Kato H; Kajiwara R; Tanaka F; Goto H; Yokota S
    Turk J Haematol; 2016 Dec; 33(4):331-334. PubMed ID: 27094503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute megakaryoblastic leukemia in children: treatment with bone marrow transplantation.
    de Oliveira JS; Sale GE; Bryant EM; Sanders J; Buckner CD
    Bone Marrow Transplant; 1992 Nov; 10(5):399-403. PubMed ID: 1463999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.